| Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960) |
|---|
| 04/01/2009 | EP2041144A1 Substituted benzoxepino-isoxazoles and use thereof |
| 04/01/2009 | EP1768987B1 (r/s) rifamycin derivatives, their preparation and pharmaceutical compositions |
| 04/01/2009 | EP1506175B1 N-substituted tricyclic 3-aminopyrazoles as pdgf receptor inhibitors |
| 04/01/2009 | EP1473295B1 Fused bicyclic pyrimidine derivatives |
| 04/01/2009 | CN101400668A 2-(cyclic amino)-pyrimidone derivatives as TPK1 inhibitors |
| 03/31/2009 | US7511071 Thioamide derivatives as progesterone receptor modulators |
| 03/31/2009 | US7511066 Antithrombotic aromatic ethers |
| 03/31/2009 | US7511057 Triazolopyridinylsulfanyl derivatives as p38 MAP kinase inhibitors |
| 03/31/2009 | US7511056 TGF-β inhibitors |
| 03/31/2009 | US7511053 Spiroazacyclic compounds as monoamine receptor modulators |
| 03/31/2009 | US7511037 N-[[4-fluoro-2-(5-methy-1H-1,2,4-triazol-1-yl)phenyl]methyl]-4-,6,7,9-tetrahydro-3-hydroxy-9,9-dimethyl-4-oxo-pyrimido[2,1-c][1,4]oxazine-2-carboxamide as an HIV integrase inhibitor |
| 03/31/2009 | US7511035 6-{[(2-{4-[3-fluoro-6-(methyloxy)-1,5-naphthyridin-4-yl]-1-piperazinyl}ethyl)amino]methyl}-2H-pyrido[3,2-b][1,4]thiazin-3-one; bacterial infections; antibiotic resistance; Staphylococcus aureus, Streptococcus pneumoniae and pyogenes, Enterococcus; Haemophilus influenzae, Moraxella catarrhalis, E-coli |
| 03/31/2009 | CA2441313C New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors |
| 03/26/2009 | WO2009037394A2 6-cycloamino-s-(pyridazin-4-yl)imidazo[1,2-b]-pyridazine and derivatives thereof preparation and therapeutic application thereof |
| 03/26/2009 | WO2009037296A1 Compounds which have activity at m1 receptor and their uses in medicine |
| 03/26/2009 | WO2009037294A1 Compounds which have activity at m1 receptor and their uses in medicine |
| 03/26/2009 | WO2009016462A3 Substituted bicyclolactam compounds |
| 03/26/2009 | WO2008126943A3 Method for manufacturing neuraminic acid derivatives |
| 03/26/2009 | WO2008106058A3 Inhibitors of serine proteases |
| 03/26/2009 | US20090082558 distillation; precipitation; storage stability |
| 03/26/2009 | CA2693116A1 6-cycloamino-s-(pyridazin-4-yl)imidazo[1,2-b]-pyridazine and derivatives thereof preparation and therapeutic application thereof |
| 03/25/2009 | EP2039685A2 Heterobicyclic compounds as P38 inhibitors |
| 03/25/2009 | EP2038281A2 Nicotinic agonists selective for the alpha7 receptor subtype, the process for the preparation thereof and pharmaceutical compositions therefrom |
| 03/25/2009 | EP2038264A1 Tetrazole-substituted arylamides |
| 03/25/2009 | EP1756063A4 Amido compounds and their use as pharmaceuticals |
| 03/25/2009 | EP1635641B1 Mitotic kinesin inhibitors |
| 03/25/2009 | EP1504010B1 Vitamin-mitomycin conjugates |
| 03/25/2009 | CN101392001A Carboxamides derivates, preparation method thereof and use on medicine |
| 03/24/2009 | US7507836 Benzamide modulators of metabotropic glutamate receptors |
| 03/24/2009 | US7507752 A C9-deoxomeridamycin, used as a neuroregenerative agent |
| 03/24/2009 | US7507746 Enantiomer of tenatoprazole and the use thereof in therapy |
| 03/24/2009 | CA2422380C Pyrazole compounds useful as protein kinase inhibitors |
| 03/19/2009 | WO2009035684A1 Spirocyclic aminoquinolones as gsk-3 inhibitors |
| 03/19/2009 | WO2009035634A2 Cyanoaminoquinolones and tetrazoloaminoquinolones as gsk-3 inhibitors |
| 03/19/2009 | WO2009018551A3 Therapeutic compounds |
| 03/19/2009 | WO2008153793A3 Gamma secretase modulators |
| 03/19/2009 | US20090076263 Elimination of heterogeneous or mixed cell population in tumors |
| 03/19/2009 | US20090076060 Deuterium-enriched temsirolimus |
| 03/19/2009 | US20090076001 Substituted 4,5,6,7 -Tetrahydro-Isoxazolo[4,5-C]Pyridine Compounds and Use Thereof for Producing Medicaments |
| 03/19/2009 | US20090075999 Oxygen linked pyrimidine derivatives |
| 03/19/2009 | US20090075978 Substituted propiolic acid amides and their use for producing drugs |
| 03/19/2009 | US20090075938 Treatment of duchenne muscular dystrophy |
| 03/19/2009 | US20090075869 HCV NS3 protease inhibitors |
| 03/19/2009 | US20090074858 Sustained-release formulation |
| 03/19/2009 | CA2699152A1 Spirocyclic aminoquinolones as gsk-3 inhibitors |
| 03/19/2009 | CA2699151A1 Cyanoaminoquinolones and tetrazoloaminoquinolones as gsk-3 inhibitors |
| 03/18/2009 | EP2036910A1 Benzoxazine-based monomer, polymer thereof, electrode for fuel cell including the same, electrolyte membrane for fuel cell includind the same, and fuel cell using the same |
| 03/18/2009 | EP2036909A1 Quaternary ammonium salt compounds of spirocyclopiperazines, preparation methods and uses thereof |
| 03/18/2009 | EP2036889A2 Substituted indoles and a method for the production and use thereof |
| 03/18/2009 | EP1458720B1 1,8-annelated quinoline derivatives substituted with carbon-linked triazoles as farnesyl transferase inhibitors |
| 03/18/2009 | EP1386912B1 Cyclic amidine derivative |
| 03/18/2009 | CN101389632A Spiroketals |
| 03/18/2009 | CN101386623A Preparation of 1-aza-2-oxa-dibenzo[e,h]azulenes and their medical use |
| 03/18/2009 | CN100469778C Novel fused imidazole derivative |
| 03/17/2009 | US7504432 Quaternary salt of (3-((2-(3,3-difluorocyclopentyl)-2-hydroxy-2-(4-methylphenyl)ethanoyl)oxy)-1,1-dimethylpyrrolidinium bromide; respiratory system disorders; chronic obstructive pulmonary diseases, bronchitis, asthma, emphysema, rhinitis; side effect reduction; inhalants; muscarinic receptor antagonists |
| 03/17/2009 | US7504412 Melanin concentrating hormone receptor antagonists; such as n-(2-cyclopropyl-3-methylimidazo[1,2-a]-pyridin-6-yl)-4-(2-pyridyl)benzamide; central nervous system, cardiovascular and metabolic disorders; synthesis |
| 03/17/2009 | US7504390 Benzoxazepine derivatives and their use as AMPA receptor stimulators |
| 03/17/2009 | CA2385461C Regioselective synthesis of rapamycin derivatives |
| 03/12/2009 | WO2009032723A1 Perfluoro macrocycles in 18f-labelling of macromolecules |
| 03/12/2009 | WO2009032123A2 Tetracyclic indole derivatives and their use for treating or preventing viral infections |
| 03/12/2009 | US20090069560 Process For Obtaining Levofloxacin Free From Salts |
| 03/12/2009 | US20090069533 Benzoxazine monomers, polymers and compositions |
| 03/12/2009 | US20090069280 17-amino analogs of geldanamycin, used for treating and modulating disorders associated with hyperproliferation, such as cancer; antiproliferative and anticarcinogenic agents |
| 03/12/2009 | US20090068266 Sirolimus having specific particle size and pharmaceutical compositions thereof |
| 03/12/2009 | CA2697451A1 Tetracyclic indole derivatives and methods of use thereof |
| 03/11/2009 | EP2032577A1 Long wavelength shifted benzotriazole uv-absorbers and their use |
| 03/11/2009 | EP2032535A1 Spirocyclic nitriles as protease inhibitors |
| 03/11/2009 | EP1620440B1 Synthesis of substituted heterocyclic compounds |
| 03/11/2009 | CN101384604A Ethanol or 1,2-ethanediol cyclohexyl antibiotic derivatives |
| 03/11/2009 | CN101384590A Oxazoloisoquinoline derivatives as thrombin receptor antagonists |
| 03/11/2009 | CN101381372A Pazufloxacin mesylate and preparation method of powder for injection |
| 03/11/2009 | CN101381365A Dual action antibiotics |
| 03/11/2009 | CN101381361A Organic compound for recording layer and optical recording medium including the same |
| 03/10/2009 | US7501523 reacting an oligomer consisting of 2-11 linked glycolurils or analogues with one or more compounds selected from glycoluril, glycoluril analogues and/or oligomers of glycoluril or glycoluril analogues, in the presence of an acid, and a template (dimethylaminobenzaldehyde) to form a cucurbit(n)uril |
| 03/10/2009 | US7501438 1-(3-naphthalen-1-yl-imidazo[1,5-a]pyridin-1-yl)-butan-1-one; chronic pain, an inflammatory disorder, rheumatoid arthritis, multiple sclerosis, osteoporosis and osteoarthritis; cannabinoid receptor ligands |
| 03/10/2009 | US7501430 e.g. 3-{5-[2-({(3R)-1-[(4-chlorophenyl)sulfonyl]piperidin-3-yl}amino)pyrimidin-4-yl]imidazo[2,1-b][1,3]thiazol-6-yl}phenyl carbamate; antiproliferative, anticarcinogenic agent; cell proliferative disorders |
| 03/10/2009 | US7501427 Such as N6-(4,5-dihydrooxazol-2-yl)-N4-[3-methyl-4-(6-methylpyridin-3-yloxy)-phenyl]-quinazoline-4,6-diamine; for treatment of hyperproliferative disorders such as cancer |
| 03/10/2009 | US7501418 e.g. 3-[4-(2-Methyl-3-phenyl-allyl)-piperazin-1-ylmethyl]-3a,4-dihydro-3H-2,5-dioxa-1,7-diaza-dicyclopenta[a,g]naphthalene; serotonine (5-HT) reuptake inhibitor, alpha 2-adrenoceptor antagonist; antidepressant, anxiolytic agent; Parkinson's disease, eating disorders, psychosis, obesity |
| 03/10/2009 | US7501412 e.g. 4-(1-(2-hydroxyethyl)piperidin-4-yl)-2H-isoquinolin-1-one; poly(ADP-ribose)polymerase inhibitor; nicotinamide nucleotide (NAD) substrate; acute cerebral infarction |
| 03/10/2009 | CA2374999C Method for separating analogous organic compounds |
| 03/05/2009 | WO2009028588A1 Polycyclic compound |
| 03/05/2009 | WO2009027732A1 5-6-bicyclic heteroaromatic compounds with antibacterial activity |
| 03/05/2009 | WO2009004382A3 3-spiropyrimidinetrione-quinoline derivatives and their use as antibacterial agents |
| 03/05/2009 | WO2008118328A3 Process and intermediates for the synthesis of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one compounds |
| 03/05/2009 | WO2005121138A3 Heterotricyclic compounds for use as hcv inhibitors |
| 03/05/2009 | US20090062532 Chemical Intermediate |
| 03/05/2009 | US20090062529 Multi-cyclic compounds |
| 03/05/2009 | US20090062267 L-ALANINE DERIVATIVES AS a5beta1 ANTAGONISTS |
| 03/05/2009 | US20090062265 6-({4-[(2,3-Dihydro[1,4]dioxino[2,3-c]pyridin-7-ylmethyl)amino]-1-piperidinyl}methyl)-7-fluoro-5,6-dihydro-3H-pyrrolo[1,2,3-de]quinoxalin-3-one; may be formulated for administration in any convenient way for use in human or veterinary medicine |
| 03/05/2009 | US20090062253 Heterocyclodiazepine cannabinoid receptor modulators for treatment of disease |
| 03/05/2009 | US20090062250 Soluble 17-amino-analogs of geldanamycin in acid addition salt form; water solubility; anticancer agents; storage stability |
| 03/05/2009 | US20090060888 Regulated transcription of targeted genes and other biological events |
| 03/04/2009 | EP2029611A2 17-desmethylrapamycin and analogues thereof, methods for their production and their use as immunosupressants, anticancer agents, antifungal agents etc. |
| 03/04/2009 | EP1948626B1 Process for the preparation of delmopinol and derivatives thereof |
| 03/04/2009 | EP1546150B1 Pyrrole derivatives as inhibitors of cyteine proteases |
| 03/04/2009 | EP1427720B1 3-substituted-4-pyrimidone derivatives |
| 03/04/2009 | CN101379055A Substituted quinolones III |
| 03/04/2009 | CN101376661A Novel preparation of fenspiride |
| 03/04/2009 | CN100465177C An oxygen, nitrogen heterocyclic naphthoyl imine kind compound and a biological application thereof |
| 03/03/2009 | US7498438 Fused ring NK1 antagonists |